Production (Stage)
Restart Life Sciences Corp.
NMLSF
$0.048
$0.011531.51%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 270.20K | 118.10K | 185.50K | 8.80K | 16.10K |
Total Receivables | 12.10K | 7.90K | 4.20K | 3.00K | 5.50K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 282.30K | 126.00K | 189.70K | 11.80K | 21.60K |
|
|||||
Total Current Assets | 282.30K | 126.00K | 189.70K | 11.80K | 21.60K |
Net Property, Plant & Equipment | 6.00K | 6.30K | 7.10K | 7.50K | 8.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 288.20K | 132.30K | 196.80K | 19.30K | 29.60K |
|
|||||
Total Accounts Payable | 85.50K | 134.90K | 199.80K | 443.10K | 443.40K |
Total Accrued Expenses | 17.60K | 146.90K | 386.40K | 296.30K | 247.10K |
Short-term Debt | -- | 58.30K | 44.40K | 43.80K | 44.30K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 103.10K | 340.20K | 630.60K | 783.20K | 734.90K |
|
|||||
Total Current Liabilities | 103.10K | 340.20K | 630.60K | 783.20K | 734.90K |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | 58.30K | 44.40K | 43.80K | 44.30K |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 103.10K | 340.20K | 630.60K | 783.20K | 734.90K |
|
|||||
Common Stock & APIC | 35.77M | 35.11M | 37.20M | 36.72M | 37.12M |
Retained Earnings | -41.66M | -41.05M | -43.72M | -43.49M | -43.89M |
Treasury Stock & Other | 6.07M | 5.73M | 6.08M | 6.00M | 6.07M |
Total Common Equity | 185.20K | -207.90K | -433.80K | -763.90K | -705.20K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 185.20K | -207.90K | -433.80K | -763.90K | -705.20K |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 185.20K | -207.90K | -433.80K | -763.90K | -705.20K |
|